急求！一小段临床研究方面的英文翻译成中文，非常感谢！

This NDA submission containsdata supplied by the Sponsor from 9 trials. All nine trials wer#conducted underthe drug、IND. Three out of the 9 trials are pharmacokinetic studies. (See the PK review for furtherinformation about these trials.) Of theremaining 6 trials, 3 are clinical efficacy and safety studies in post-herpeticneuralgia (PHN) and venepuncture, 2 are contact irritancy trials, and 1is aphotosensitivity study. Of the 2 clinical efficacy and safety studies in PHN,one is the pivotal Phase 3 trial the Sponsor conducted for the proposedindication, while the other is a small, Phase 2 trial which was the basis forthe design and plan of the larger, Phase 3 trial. These 2 trials, are discussedin detail along with the venepuncture trial in the efficacy portion of thisreview. The 3 dermal safety trials, which followed standardized protocols, arerequired to document a topical drug’s safety profile. They are brieflydiscussed in the Special Studies subsection of the safety review. (See Section 10.2.3 SpecialStudies.)